Michel Ticchioni

ORCID: 0000-0002-9949-0411
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Chronic Lymphocytic Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Immune Cell Function and Interaction
  • HIV Research and Treatment
  • Immunodeficiency and Autoimmune Disorders
  • T-cell and B-cell Immunology
  • Cell Adhesion Molecules Research
  • Immunotherapy and Immune Responses
  • Advanced Breast Cancer Therapies
  • Monoclonal and Polyclonal Antibodies Research
  • Histone Deacetylase Inhibitors Research
  • CAR-T cell therapy research
  • Phagocytosis and Immune Regulation
  • Myasthenia Gravis and Thymoma
  • Acute Lymphoblastic Leukemia research
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Cancer Mechanisms and Therapy
  • Peripheral Neuropathies and Disorders
  • Single-cell and spatial transcriptomics
  • Platelet Disorders and Treatments
  • Acute Myeloid Leukemia Research
  • Multiple Sclerosis Research Studies
  • Mast cells and histamine
  • Melanoma and MAPK Pathways
  • Cell death mechanisms and regulation

Université Côte d'Azur
2007-2025

Hôpital l'Archet
2011-2024

Inserm
2001-2023

Institut National de Recherche en Santé Publique
2007-2023

Centre Hospitalier Universitaire de Nice
2009-2021

Institut de Biologie Valrose
2021

Centre Méditerranéen de Médecine Moléculaire
2021

Hôpital Pasteur
2016-2017

Centre Hospitalier de Cannes
2015

Medical University of Vienna
2006

An impaired inhibitory function of circulating CD4+CD25+ regulatory T (Treg) cells was reported to play a key role in alopecia areata (AA). We report the first use our knowledge low-dose interleukin 2 for treating severe AA by promoting recruitment Treg cells.We conducted prospective open pilot study 5 patients with resistant previous systemic treatments. Subcutaneous (1.5 million IU/d) administered during days, followed three 5-day courses 3 IU/d at weeks 3, 6, and 9. The primary outcome...

10.1001/jamadermatol.2014.504 article EN JAMA Dermatology 2014-05-28

CD47 on the surface of T cells was shown in vitro to mediate either cell activation or, presence high amounts thrombospondin (TSP), apoptosis. We report here that CD47-deficient mice, as well TSP-1 or TSP-2-deficient sustain oxazolone-induced inflammation for more than four days, whereas wild-type mice reduce within 48 h. observe prolonged CD47-, TSP-1-, is accompanied by a local deficiency Finally, we show upon normal increase expression proapoptotic Bcl-2 family member BNIP3...

10.4049/jimmunol.178.9.5930 article EN The Journal of Immunology 2007-05-01

Different rituximab protocols are used to treat membranous nephropathy. We compared two in patients with nephropathy.Twenty-eight participants from the NICE cohort received infusions of 1-g at 2-week intervals, whereas 27 Prospective Randomized Multicentric Open Label Study Evaluate Rituximab Treatment for Membranous Nephropathy (GEMRITUX) 375 mg/m2 1-week interval. measured serum levels and remission month 6 before any treatment modification analyzed factors associated relapses.Remissions...

10.2215/cjn.11791018 article EN Clinical Journal of the American Society of Nephrology 2019-07-24
Francine Garnache‐Ottou Chrystelle Vidal Sabeha Biichlé Florian Renosi Eve Poret and 95 more Maïder Pagadoy Maxime Desmarets Anne Roggy Estelle Seillès Lou Soret Françoise Schillinger Sandrine Puyraimond Tony Petrella Claude Preudhomme Christophe Roumier Elisabeth Macintyre Véronique Harrivel Yohan Desbrosses Bérengère Gruson Franck Geneviève Sylvain Thépot Yuriy Drebit Thibaut Leguay François‐Xavier Gros Nicolas Lechevalier Pascale Saussoy Véronique Salaün Édouard Cornet Zehaira Benseddik Richard Veyrat‐Masson Orianne Wagner‐Ballon Célia Salanoubat Marc Maynadié Julien Guy Denis Caillot Marie‐Christine Jacob Jean‐Yves Cahn Rémy Gressin Johann Rose Bruno Quesnel Estelle Guérin Franck Trimoreau Jean Feuillard Marie-Pierre Gourin Adriana Pleşa Lucile Baseggio Isabelle Arnoux Norbert Vey Didier Blaise Romaric Lacroix Christine Arnoulet Blandine Bénet Véronique Dorvaux Caroline Bret Bernard Drénou Agathe Debliquis Véronique Latger‐Cannard Caroline Bonmati Marie C. Béné Pierre Péterlin Michel Ticchioni Pierre‐Simon Rohrlich Anne Arnaud Stefan Wickenhauser Valérie Bardet Sabine Bréchignac Benjamin Papoular Victoria Raggueneau Jacques Vargaftig Rémi Letestu Daniel Lusina Thorsten Braun Vincent Foissaud Jérôme Tamburini Hind Bennani Nicolas Freynet Catherine Cordonnier Magali Le Garff‐Tavernier Nathalie Jacques Karim Maloum Damien Roos‐Weil Didier Bouscary Vahid Asnafi Ludovic Lhermitte Felipe Suárez Étienne Lengliné Frédéric Féger Giorgia Battipaglia Mohamad Mohty Sabrina Bouyer Ouda Ghoual Elodie Dindinaud Caroline Baslé Mathieu Puyade Carinne Lecoq Lafon Thierry Fest Mikaël Roussel Xavier Cahu Elsa Bera Sylvie Daliphard

Abstract Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia for which we developed nationwide network to collect data from new cases diagnosed in France. In retrospective, observational study of 86 patients (2000-2013), described clinical biological focusing on morphologies immunophenotype. We found expression markers associated with origin (HLA-DRhigh, CD303+, CD304+, cTCL1+) plus CD4 CD56 frequent isolated the myeloid, B-, T-lymphoid lineages, whereas...

10.1182/bloodadvances.2019000647 article EN cc-by-nc-nd Blood Advances 2019-12-23

GPI-anchored surface proteins mediate many important functions, including transport, signal transduction, adhesion, and protection against complement. They cluster into glycolipid-based membrane domains caveolae, plasmalemmal vesicles involved in the transcytosis endocytosis of these proteins. However, lymphocytes, neither characteristic flask shaped caveolae nor caveolin, a transmembrane protein typical have been observed. Here, we show that CD59 molecule on Jurkat T cells is internalized...

10.1083/jcb.133.4.791 article EN The Journal of Cell Biology 1996-05-15

The SARS-CoV-2 infection has spread rapidly around the world causing millions of deaths. Several treatments can reduce mortality and hospitalization. However, their efficacy depends on choice molecule precise timing its administration to ensure viral clearance avoid a deleterious inflammatory response. Here, we investigated IFN-γ, assessed by functional immunoassay, as predictive biomarker for risk hospitalization at an early stage or within one month prior infection. Individuals with IFN-γ...

10.3389/fimmu.2022.953502 article EN cc-by Frontiers in Immunology 2022-09-26

Abstract The clinical course of patients with chronic lymphocytic leukemia (CLL) is heterogeneous some requiring early therapy whereas others will not be treated for years. evaluation an individual CLL patient's prognosis remains a problematic issue. presence or absence somatic mutations in the IgVH genes currently gold‐standard prognostic factor, but this technique labor intensive and costly. Genomic studies uncovered that 70 kDa zeta‐associated protein (ZAP‐70) expression was associated...

10.1002/cyto.b.20132 article EN Cytometry Part B Clinical Cytometry 2006-07-15

Abstract BACKGROUND. To the authors' knowledge, genetic abnormalities in early‐stage chronic lymphocytic leukemia (CLL) have not been examined fully. Single nucleotide polymorphism (SNP) genomic array (SNP‐chip) is a new tool that can detect copy number changes and uniparental disomy (UPD) over entire genome with very high resolution. METHODS. The authors performed SNP‐chip analysis on 56 samples from patients early‐stage, untreated CLL. validate data, fluorescence situ hybridization (FISH)...

10.1002/cncr.23270 article EN Cancer 2008-02-01

Objective: To assess changes over time in neuropsychological test results (NPr) and risk factors among a regularly followed HIV-infected patient population. Methods: Prospective cohort of patients randomly selected to undergo follow-up. Test score was adjusted for age, sex education. Patients were divided into five groups: normal tests, deficit (one impaired cognitive domain), asymptomatic neurocognitive disorders (ANIs), mild (MNDs) HIV-associated dementia (HAD). Demographic background...

10.1097/qad.0000000000000096 article EN AIDS 2013-10-18

Blastic plasmacytoid dendritic cell neoplasm is an aggressive malignancy derived from cells. There currently no accepted standard of care for treating this neoplasm, and therapeutic strategies have never been prospectively evaluated. Since blastic cells express high levels interleukin-3 receptor α chain (IL3-Rα or CD123), antitumor effects the receptor-targeted drug SL-401 against were evaluated in vitro vivo. The cytotoxicity was assessed patient-derived lines (CAL-1 GEN2.2) primary...

10.3324/haematol.2014.111740 article EN cc-by-nc Haematologica 2014-11-07

Abstract IAP is a glycoprotein functionally and physically associated with some integrins, i.e., the leukocyte response integrin beta3 chain on placenta, platelets, polymorphonuclear cells. may act as transducer element in activation mediated via these integrins. Since present at high density peripheral T lymphocytes we have investigated its involvement cell activation. We tested three mAbs against IAP, namely B6H12, BRIC126, 2D3, which recognize two distinct epitopes. cross-linking B6H12 or...

10.4049/jimmunol.158.2.677 article EN The Journal of Immunology 1997-01-15

Abstract Loss of tumor-suppressive pathways that control cellular senescence is a crucial step in malignant transformation. Spleen tyrosine kinase (Syk) cytoplasmic has been recently implicated tumor suppression melanoma, deadly skin cancer derived from pigment-producing melanocytes. However, the mechanism by which Syk suppresses melanoma growth remains unclear. Here, we report reexpression cells induces p53-dependent expression cyclin-dependent (cdk) inhibitor p21 and program. We first...

10.1158/0008-5472.can-08-2690 article EN Cancer Research 2009-03-18

Abstract The glycosylphosphatidylinositol (GPI)‐anchored CD59 protein (human protectin) protects cells against complement‐induced lysis, binds to CD2 and also transduces activation signals within T cells. We have further examined the biochemical transduced by addressed its role in regard CD3‐mediated signaling cascade. show here that cross‐linking induces a time‐dependent of p56 lck p70 zap (ZAP‐70) CD3‐positive Jurkat cells, leading stimulation cell receptor ζ/ZAP‐70 cascade interleukin‐2...

10.1002/eji.1830250704 article EN European Journal of Immunology 1995-07-01

CD99/E2 is an integral transmembrane protein which forms, together with Xga, a distinct family whose genes are located in the pseudoautosomal region. The number of T cells that firmly bound to vascular endothelial under physiological shear stress increased 2–14-fold upon CD99 stimulation, and became much more resistant detachment forces spread. cell arrest occurred within 1 min was dependent on α4β1-VCAM-1 pathway. In contrast, αLβ2-ICAM-1 pathway remained unactivated. This observed lines...

10.1002/1521-4141(200010)30:10<3061::aid-immu3061>3.0.co;2-m article EN European Journal of Immunology 2000-10-01
Coming Soon ...